1. The 2008 EORTC/MSG consensus definitions: What’s new? What’s next?

   • Nikolaos G. Almyroudis
   • Brahm H. Segal

   OriginalPaper 10 November 2009 Pages: 195 - 200

2. Galactomannan detection in nonserum specimens: Where do we stand?

   • Greet De Vlieger
   • Katrien Lagrou
   • Wouter Meersseman

   OriginalPaper 10 November 2009 Pages: 201 - 206

3. Polymerase chain reaction diagnosis of fungal disease: Finally coming of age

   • P. Lewis White
   • Michael D. Perry
   • Rosemary A. Barnes

   OriginalPaper 10 November 2009 Pages: 207 - 215

4. Diagnosis of aspergillosis: Role of proteomics

   • Leonardo Potenza
   • Patrizia Barozzi
   • Mario Luppi

   OriginalPaper 10 November 2009 Pages: 216 - 222

5. New developments in the treatment of zygomycosis

   • George L. Petrikkos
   • Anna Skiada

   OriginalPaper 10 November 2009 Pages: 223 - 228

6. Treatment of breakthrough fungal infections: Is there one best drug strategy?

   • Michael D. Nailor
   • Pranatharthi H. Chandrasekar

   OriginalPaper 10 November 2009 Pages: 229 - 235

7. Azole resistance in aspergillosis: The next threat?

   • Cornelia Lass-Flörl

   OriginalPaper 10 November 2009 Pages: 236 - 242

8. Immunomodulating effects of antifungal therapy

   • Konstantinos Leventakos
   • Ronen Ben-Ami
   • Dimitrios P. Kontoyiannis

   OriginalPaper 10 November 2009 Pages: 243 - 250